Gym peptides on TikTok: separating hype from human data

What did @landotalkspeps actually say?

The creator walked through a compound they called "IGF-103," describing it as something that "works directly at muscle cell level" by binding IGF-1 receptors, driving protein synthesis, and triggering hypertrophy pathways. They laid out a dosing progression starting at 20 to 40 micrograms, scaling to 60 to 80 micrograms, across an 8-week cycle with an 8-week break. They also covered reconstitution using bacteriostatic water and recommended post-workout timing based on insulin sensitivity and elevated muscle blood flow. The disclaimer at the end called it "educational purposes only."

That framing is worth noting upfront. Educational or not, a video with 56,000 views giving specific dose ranges and cycle protocols is functionally guiding people toward self-administering an unregulated injectable compound. That context matters for everything that follows.

Does the science back this up?

Here is the first problem: "IGF-103" does not appear in peer-reviewed literature, any known regulatory filing, or established peptide pharmacology references. The compound name itself is unverifiable. This is not a minor quibble. It is the foundational issue with this video.

IGF-1 (insulin-like growth factor 1) is a real, well-studied hormone. Its role in muscle protein synthesis and hypertrophy signaling through the PI3K/Akt/mTOR pathway is documented. Research by Goldspink (2005, Journal of Anatomy) and later work on mechano growth factor variants established that IGF-1 splice variants do play a role in muscle repair and growth. There are also analogs and truncated peptides in various stages of research. However, none of them are commercially available as "IGF-103." The creator appears to be describing something either mislabeled in the gray-market supply chain or invented outright. Either scenario is a serious red flag for anyone considering purchasing this.

What did they get wrong (or right)?

The mechanistic explanation, that IGF-1 receptors on muscle cells mediate protein synthesis and hypertrophy signaling, is broadly consistent with established endocrinology. That part is not wrong. The post-workout timing rationale, citing "insulin sensitive" muscles and elevated blood flow, also reflects real physiology. Insulin sensitivity in skeletal muscle is indeed elevated after resistance exercise, as shown by Richter and Hargreaves (2013, Physiological Reviews). Credit where it is due.

What they got wrong is more significant. The compound name "IGF-103" has no verifiable identity. The dosing protocol presented as common practice has no clinical trial backing it. The reconstitution guidance, while procedurally reasonable for peptide handling, is being applied to a substance of unknown composition and purity. And describing this compound as "a tool to amplify what your body's already doing" smooths over risks that include hypoglycemia, potential mitogenic effects, and the fact that gray-market injectables carry real contamination risks.

What should you actually know?

If you are searching for this compound because of this video, stop and do this one thing first: ask the seller for a certificate of analysis from a third-party lab. If they cannot provide one, you do not know what is in the vial. Gray-market peptide products have been found to contain incorrect concentrations, bacterial contamination, and in some cases entirely different compounds than labeled. A 2018 investigation by Cohen et al. (JAMA Internal Medicine) found widespread mislabeling in bodybuilding supplement products, a pattern that extends into the injectable peptide market.

IGF-1 itself is not an approved therapeutic for general muscle building in healthy adults. It is approved in specific pediatric growth disorders. Exogenous IGF-1 administration in healthy individuals carries theoretical cancer promotion risks given IGF-1's role in cell proliferation, a concern raised repeatedly in epidemiological literature including work by Pollak (2012, Nature Reviews Cancer). None of this means research into IGF-1 analogs is without merit. It means a TikTok video is not where you should be getting your safety framework.

• The compound name "IGF-103" is not found in clinical literature or regulatory databases.
• Post-workout timing logic is physiologically reasonable but applied to an unverified compound.
• Gray-market injectables carry contamination and mislabeling risks with no consumer protection.
• IGF-1 pathway manipulation in healthy adults has not been proven safe in long-term human trials.

Bottom line

The creator understands IGF-1 receptor biology well enough to sound credible. That is precisely what makes this video more dangerous, not less. Wrapping an unverifiable compound in accurate mechanistic language does not make the compound real or safe. FormBlends does not endorse sourcing, dosing, or cycling any compound that lacks a verified identity and peer-reviewed safety data in humans.